These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32985057)

  • 1. Pediatric diabetes and skin disease (PeDiSkin): A cross-sectional study in 369 children, adolescents and young adults with type 1 diabetes.
    Burgmann J; Biester T; Grothaus J; Kordonouri O; Ott H
    Pediatr Diabetes; 2020 Dec; 21(8):1556-1565. PubMed ID: 32985057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequencies of dermatological complications in children using insulin pumps or sensors.
    Berg AK; Olsen BS; Thyssen JP; Zachariae C; Simonsen AB; Pilgaard K; Svensson J
    Pediatr Diabetes; 2018 Jun; 19(4):733-740. PubMed ID: 29484783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin Problems Associated with Insulin Pumps and Sensors in Adults with Type 1 Diabetes: A Cross-Sectional Study.
    Berg AK; Nørgaard K; Thyssen JP; Zachariae C; Hommel E; Rytter K; Svensson J
    Diabetes Technol Ther; 2018 Jul; 20(7):475-482. PubMed ID: 29893593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of insulin regimen and glucose outcomes with short-term real-time continuous glucose monitoring (RT-CGM) in type 1 diabetic children with sub-optimal glucose control on multiple daily injections: The pediatric DIACCOR study.
    Picard S; Bonnemaison-Gilbert E; Leutenegger E; Barat P
    Arch Pediatr; 2019 Feb; 26(2):95-101. PubMed ID: 30642746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Satisfaction with continuous glucose monitoring is associated with quality of life in young people with type 1 diabetes regardless of metabolic control and treatment type.
    Franceschi R; Pertile R; Marigliano M; Mozzillo E; Maffeis C; Morotti E; Di Candia F; Fedi L; Iafusco D; Zanfardino A; Cauvin V; Maltoni G; Zucchini S; Cherubini V; Tiberi V; Minuto N; Bassi M; Rabbone I; Savastio S; Tinti D; Tornese G; Schiaffini R; Passanisi S; Lombardo F; Bonfanti R; Scaramuzza A; Troncone A
    Diabet Med; 2024 Jun; 41(6):e15307. PubMed ID: 38383984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous Reactions to Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion Devices in Type 1 Diabetes Mellitus.
    Rigo RS; Levin LE; Belsito DV; Garzon MC; Gandica R; Williams KM
    J Diabetes Sci Technol; 2021 Jul; 15(4):786-791. PubMed ID: 32389062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Description of the Skin Reactions Associated with Adhesives in Diabetes Technology Devices in an Adult Population: Results of the CUTADIAB Study.
    Diedisheim M; Pecquet C; Julla JB; Carlier A; Potier L; Hartemann A; Jacqueminet S; Vidal-Trecan T; Gautier JF; Dubois Laforgue D; Fagherazzi G; Roussel R; Larger E; Sola-Gazagnes A; Riveline JP
    Diabetes Technol Ther; 2023 Apr; 25(4):279-286. PubMed ID: 36763338
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolonged use of continuous glucose monitors in children with type 1 diabetes on continuous subcutaneous insulin infusion or intensive multiple-daily injection therapy.
    ; Weinzimer S; Xing D; Tansey M; Fiallo-Scharer R; Mauras N; Wysocki T; Beck R; Tamborlane W; Ruedy K
    Pediatr Diabetes; 2009 Apr; 10(2):91-6. PubMed ID: 19175899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
    Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E;
    Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technology use and clinical outcomes in a racial-ethnic minority cohort of children and adolescents with type 1 diabetes.
    Baboun D; Solano N; Del Toro V; Alvarez-Salvat R; Granados A; Carrillo-Iregui A
    J Pediatr Endocrinol Metab; 2023 Dec; 36(12):1128-1132. PubMed ID: 37852007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life in Danish children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion or multiple daily injections.
    Birkebaek NH; Kristensen LJ; Mose AH; Thastum M;
    Diabetes Res Clin Pract; 2014 Dec; 106(3):474-80. PubMed ID: 25451903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of flash glucose-sensing technology (FreeStyle Libre) in youth with type 1 diabetes: AWeSoMe study group real-life observational experience.
    Landau Z; Abiri S; Gruber N; Levy-Shraga Y; Brener A; Lebenthal Y; Barash G; Pinhas-Hamiel O; Rachmiel M
    Acta Diabetol; 2018 Dec; 55(12):1303-1310. PubMed ID: 30171412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preserving Skin Integrity with Chronic Device Use in Diabetes.
    Messer LH; Berget C; Beatson C; Polsky S; Forlenza GP
    Diabetes Technol Ther; 2018 Jun; 20(S2):S254-S264. PubMed ID: 29916740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergic contact dermatitis in pediatric patients with type 1 diabetes: An emerging issue.
    Lombardo F; Salzano G; Crisafulli G; Panasiti I; Alibrandi A; Messina MF; Pajno GB; Caminiti L; Passanisi S
    Diabetes Res Clin Pract; 2020 Apr; 162():108089. PubMed ID: 32087268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. POSTPRANDIAL DOSING OF BOLUS INSULIN IN PATIENTS WITH TYPE 1 DIABETES: A CROSS-SECTIONAL STUDY USING DATA FROM THE T1D EXCHANGE REGISTRY.
    Peters A; Van Name MA; Thorsted BL; Piltoft JS; Tamborlane WV
    Endocr Pract; 2017 Oct; 23(10):1201-1209. PubMed ID: 28704103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study.
    Šoupal J; Petruželková L; Flekač M; Pelcl T; Matoulek M; Daňková M; Škrha J; Svačina Š; Prázný M
    Diabetes Technol Ther; 2016 Sep; 18(9):532-8. PubMed ID: 27482825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous subcutaneous insulin infusion versus multiple daily injection regimens in children and young people at diagnosis of type 1 diabetes: pragmatic randomised controlled trial and economic evaluation.
    Blair JC; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes DA; Gamble C;
    BMJ; 2019 Apr; 365():l1226. PubMed ID: 30944112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin Problems Due to Treatment with Technology Are Associated with Increased Disease Burden Among Adults with Type 1 Diabetes.
    Christensen MO; Berg AK; Rytter K; Hommel E; Thyssen JP; Svensson J; Nørgaard K
    Diabetes Technol Ther; 2019 Apr; 21(4):215-221. PubMed ID: 30943072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of technology on glycaemic control in type 2 diabetes: A meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion.
    Dicembrini I; Mannucci E; Monami M; Pala L
    Diabetes Obes Metab; 2019 Dec; 21(12):2619-2625. PubMed ID: 31368658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.